ARF4 Antibody | CSB-PA00915A0Rb

(No reviews yet) Write a Review
SKU:
CSB-PA00915A0Rb
Availability:
3 to 7 Working Days
  • ARF4 Antibody
  • Western blot<br />
 All lanes: ARF4 antibody at 2µg/ml<br />
 Lane 1: EC109 whole cell lysate<br />
 Lane 2: 293T whole cell lysate<br />
 Secondary<br />
 Goat polyclonal to rabbit IgG at 1/15000 dilution<br />
 Predicted band size: 21 kDa<br />
 Observed band size: 21 kDa<br />
  • Immunohistochemistry of paraffin-embedded human colon cancer using CSB-PA00915A0Rb at dilution of 1:100
  • Immunohistochemistry of paraffin-embedded human kidney tissue using CSB-PA00915A0Rb at dilution of 1:100
€315.80 - €488.70

Description

ARF4 Antibody | CSB-PA00915A0Rb | Cusabio

ARF4 Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: ARF4

Aliases: ADP-ribosylation factor 4, ARF4, ARF2

Background: GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus.

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: P18085

Host Species: Rabbit

Species Reactivity: Human

Immunogen: Recombinant Human ADP-ribosylation factor 4 protein (1-180AA)

Immunogen Species: Human

Applications: ELISA, WB, IHC

Tested Applications: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200

Purification Method: >95%, Protein G purified

Dilution Ratio1: ELISA:1:2000-1:10000

Dilution Ratio2: WB:1:500-1:5000

Dilution Ratio3: IHC:1:20-1:200

Dilution Ratio4:

Dilution Ratio5:

Dilution Ratio6:

Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4

Form: Liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Signal Transduction

Research Areas: Signal transduction

View AllClose

0 Reviews

View AllClose